Pe-22-28
Peptide therapy: benefits, side effects, cost and protocols
PE-22-28 is a synthetic peptide derived from the phosphodiesterase-4 (PDE4) inhibitor family that has been studied for nootropic and neuroprotective effects. It modulates cAMP signaling in the brain to potentially enhance memory consolidation and cognitive function.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Anecdotal
Mechanism
How Pe-22-28 works
Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.
FAQ
Pe-22-28 questions
What is PE-22-28?
PE-22-28 is a synthetic peptide analog of Spadin, researched for its potential antidepressant and cognitive-enhancing effects.
How does PE-22-28 work?
Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.
Is PE-22-28 legal to buy?
PE-22-28 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy PE-22-28?
PE-22-28 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does PE-22-28 belong to?
PE-22-28 is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.
What are the research benefits of PE-22-28?
PE-22-28 has been studied for: Antidepressant research, Mood support, Cognitive enhancement. Spadin analog; mood and cognition research.
News
Pe-22-28 in the news
Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ - PNAS
PNAS / 57 months ago
Everything You Need to Know About the FDA Peptide Ban - Hone Health
Hone Health / 33 months ago
PE-22-28 Peptide: Depression and Neurogenesis Research - Red Pepper
Red Pepper / 30 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Pe-22-28?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.